Comparative genomics and proteomics in drug discovery /
نام عام مواد
[Book]
نام نخستين پديدآور
edited by John Parrington, Kevin Coward.
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Abingdon [England] :
نام ناشر، پخش کننده و غيره
Taylor & Francis Group,
تاریخ نشرو بخش و غیره
2007.
مشخصات ظاهری
نام خاص و کميت اثر
1 online resource (xii, 182 pages) :
ساير جزييات
illustrations, maps.
فروست
عنوان فروست
Experimental biology reviews
عنوان فروست
SEB symposium series ;
مشخصه جلد
v. 58
یادداشتهای مربوط به کتابنامه ، واژه نامه و نمایه های داخل اثر
متن يادداشت
Includes bibliographical references and index.
یادداشتهای مربوط به مندرجات
متن يادداشت
Comparative genomics and drug discovery in trypanosomatids -- The practical implications of comparative kinetoplastid genomics -- The relevance of host genes in malaria -- Nicotinic acetylcholine receptors as drug/chemical targets, contributions from comparative genomics, forward and reverse genetics -- Discovery of novel sodium channel inhibitors : a gene family-based approach -- 'Omics' in translational medicine : are they lost in translation? -- Drug-target discovery in silico : using the Web to identify novel molecular targets for drug action.
بدون عنوان
0
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
"Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programmes, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds."--Jacket.
یادداشتهای مربوط به نیازمندی های سیستم (منابع الکترونیک)و جزئیات فنی
متن يادداشت
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
ویراست دیگر از اثر در قالب دیگر رسانه
عنوان
Comparative genomics and proteomics in drug discovery.